Nektar Therapeutics
Nasdaq · Healthcare · Pharmaceutical Preparations · San Francisco, CA
NKTR chart
What traders are saying about $NKTR
Latest postsNektar Therapeutics news
- Nektar Therapeutics (NKTR) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- What Nektar Therapeutics Stock's Late Stage Eczema Drug Progress Means For Shareholders
Simply Wall St ·
- Nektar Therapeutics (NKTR) stock price, news, quote and history
Yahoo Finance Singapore ·
- How New Eczema Drug Trials Will Impact Nektar Therapeutics (NKTR) Investors
Yahoo Finance ·
- Nektar Therapeutics (NKTR) Draws Fresh Eczema Buzz Following A 72% Undervalued Narrative
Simply Wall St ·
- Is Nektar Therapeutics (NKTR) Overvalued After A 407% Three Year Run?
Yahoo Finance ·
- Nektar Therapeutics News — FWB:ITH0
TradingView ·
- Profound Medical (PROF) Expected to Beat Earnings Estimates: Should You Buy?
Yahoo Finance ·
- NKTR Q3'26 Earnings: revenue estimate is 10.27M USD
TradingView ·
- Nektar (NKTR) Stock Watch: +2.19% Climb — Technical Setup Bullish 2026-11-04 - Dividend Stock Picks
https://www.dars.gov.et/ ·
- Nektar Therapeutics (NKTR) Expected to Beat Earnings Estimates: Should You Buy?
Yahoo Finance ·
- Nektar Therapeutics to Announce Financial Results for the Third Quarter on Thursday, November 12, 2026, After Close of U.S.-Based Financial Markets
Yahoo Finance ·
Nektar Therapeutics key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $55.2M | $98.4M | $90.1M | $92.1M |
| Net income | -$164.0M | -$119.0M | -$276.0M | -$368.0M |
| Diluted EPS | $-9.73 | $-8.68 | $-1.45 | $-1.97 |
| Total assets (year end) | $280.4M | $303.9M | $398.0M | $710.6M |
| Cash and equivalents (year end) | $15.1M | $44.3M | $35.3M | $88.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 10-Q10-Q
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-K8-K
- 10-Q10-Q
- 8-KCURRENT REPORT
- DEF 14ADEF 14A
- 8-K8-K
- 8-K8-K
About Nektar Therapeutics
- Ticker
- NKTR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 906709
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Frequently asked questions
What exchange is Nektar Therapeutics listed on?
Nektar Therapeutics trades on the Nasdaq under the ticker symbol NKTR.
What industry is Nektar Therapeutics in?
Nektar Therapeutics is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Nektar Therapeutics headquartered?
Nektar Therapeutics's business address on file with the SEC is in San Francisco, CA.
When does Nektar Therapeutics's fiscal year end?
Nektar Therapeutics's fiscal year ends on December 31.
How much revenue did Nektar Therapeutics report?
Nektar Therapeutics reported $55.2M in revenue for calendar year 2025, according to its SEC filings.